CNXU Conexeu Sciences Inc. - Common Stock
$8.50
Price · Aug 19, 2026
Fundamentals as of Jun 15, 2026
52W Range
$7–$19
14% of range
Analyst Rating
BUY
7 analysts
Price Target
$20
+135% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
CNXU Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$8.50
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$7 – $19
CNXU Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CNXU
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CNXU
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CNXU
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
CNXU
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CNXU
Peer Median
CNXU Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
7 analysts
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
1 analysts · 2026-08-14
Low
$20.00
High
$20.00
Median target
$20.00
+135.3%
Mean target
$20.00
+135.3%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| CNXU | — | — | — | — | — | — |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| ORGO | $658M | 34.5 | 17.0% | 6.6% | 13.9% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | Q2 2026 |
|---|---|---|
| R&D Expense | $66.6K | |
| SG&A Expense | $16.9K | |
| Operating Expenses | $2M | |
| Operating Income | $-2M | |
| Interest Expense | $0 | |
| Interest Income | $84.3K | |
| Other Non-op | $76.1K | |
| Pretax Income | $-2M | |
| Income Tax | $0 | |
| Net Income | $-2M | |
| EPS (Basic) | $-0.11 | |
| EPS (Diluted) | $-0.11 | |
| Shares (Basic) | 20,569,664 | |
| Shares (Diluted) | 20,569,664 | |
| EBITDA | $-2M |
Balance Sheet 16
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $7M | |
| Prepaid Expense | $609.5K | |
| Current Assets | $8M | |
| PP&E (Net) | $38.4K | |
| PP&E (Gross) | $49.1K | |
| Accum. Depreciation | $10.7K | |
| Intangibles | $163.9K | |
| Total Assets | $8M | |
| Accounts Payable | $455.1K | |
| Total Liabilities | $1M | |
| Common Stock | $20.9K | |
| Paid-in Capital | $16M | |
| Retained Earnings | $-9M | |
| Stockholders' Equity | $7M | |
| Liabilities + Equity | $8M | |
| Shares Outstanding | 20,916,173 |
Cash Flow 1
| Metric | Trend | Q2 2026 |
|---|---|---|
| D&A | $11.4K |
Profitability 3
| Metric | Trend | Q2 2026 |
|---|---|---|
| ROA | -56.2% | |
| ROE | -64.0% | |
| ROIC | -33.1% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Company insiders 5 insiders · 0 officers · 3 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lynn Sebastian Purcell | Director | June 18, 2026 M | 2,734,240 | 2 | 0 | $500,000 |
| Jeffrey Nathan Sharpe | Director | May 22, 2026 M | 1,000,000 | 0 | 0 | $0 |
| Zbigniew Paul Lorenc | Director | May 14, 2026 A | 433,323 | 0 | 0 | $0 |
| Michael G. Wright | 10% owner | June 18, 2026 M | 2,148,048 | 0 | 0 | $0 |
| OnePointTwo Capital Ventures LLC | 10% owner | May 12, 2026 S | 1,047,500 | 1 | 0 | $338,000 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Jeffrey Sharpe | Aug. 18, 2026 | 5.40% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.